Proactively Optimized Infliximab Monotherapy Is as Effective as Combination Therapy in IBD

Lega, S; Phan, BL; Rosenthal, CJ; Gordon, J; Haddad, N; Pittman, N; Benkov, KJ; Dubinsky, MC

Dubinsky, MC (reprint author), 1 Gustave L Levy Pl,Box 1134, New York, NY 10029 USA.

INFLAMMATORY BOWEL DISEASES, 2019; 25 (1): 134

Abstract

Background Infliximab (IFX) discontinuation is not uncommon during the first year of treatment due to inadequate drug concentrations and anti-IFX anti......

Full Text Link